Your browser doesn't support javascript.
loading
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Duployez, Nicolas; Marceau-Renaut, Alice; Villenet, Céline; Petit, Arnaud; Rousseau, Alexandra; Ng, Stanley W K; Paquet, Agnès; Gonzales, Fanny; Barthélémy, Adeline; Leprêtre, Frédéric; Pottier, Nicolas; Nelken, Brigitte; Michel, Gérard; Baruchel, André; Bertrand, Yves; Leverger, Guy; Lapillonne, Hélène; Figeac, Martin; Dick, John E; Wang, Jean C Y; Preudhomme, Claude; Cheok, Meyling.
Afiliação
  • Duployez N; Laboratory of Hematology, CHU Lille, Lille, France. nicolas.duployez@chru-lille.fr.
  • Marceau-Renaut A; UMR-S 1172, JPArc - Jean-Pierre AUBERT Research Center Neurosciences et Cancer, Univ. Lille, Inserm, CHU Lille, Lille, France. nicolas.duployez@chru-lille.fr.
  • Villenet C; Laboratory of Hematology, CHU Lille, Lille, France.
  • Petit A; UMR-S 1172, JPArc - Jean-Pierre AUBERT Research Center Neurosciences et Cancer, Univ. Lille, Inserm, CHU Lille, Lille, France.
  • Rousseau A; Functional Genomics Platform, Univ. Lille, Lille, France.
  • Ng SWK; Department of Pediatric Hematology and Oncology, APHP, Trousseau Hospital, GH HUEP, Paris, France.
  • Paquet A; Department of Clinical Pharmacology and Clinical Research Unit of East of Paris, APHP, Saint Antoine Hospital, Paris, France.
  • Gonzales F; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
  • Barthélémy A; IPMC, Université Côte d'Azur, CNRS, Valbonne, France.
  • Leprêtre F; UMR-S 1172, JPArc - Jean-Pierre AUBERT Research Center Neurosciences et Cancer, Univ. Lille, Inserm, CHU Lille, Lille, France.
  • Pottier N; Department of Pediatric Hematology-Oncology, CHU Lille, Lille, France.
  • Nelken B; UMR-S 1172, JPArc - Jean-Pierre AUBERT Research Center Neurosciences et Cancer, Univ. Lille, Inserm, CHU Lille, Lille, France.
  • Michel G; Functional Genomics Platform, Univ. Lille, Lille, France.
  • Baruchel A; Department of Biochemistry, CHU Lille, Lille, France.
  • Bertrand Y; Department of Pediatric Hematology-Oncology, CHU Lille, Lille, France.
  • Leverger G; Department of Pediatric Hematology, CHU Marseille, La Timone, Marseille, France.
  • Lapillonne H; Department of Pediatric Hematology and Immunology, APHP, Robert Debré University Hospital, Paris, France.
  • Figeac M; Institute of Hematology and Oncology Pediatrics, Hospices Civils, Claude Bernard University, Lyon, France.
  • Dick JE; Functional Genomics Platform, Univ. Lille, Lille, France.
  • Wang JCY; Laboratory of Hematology, APHP, Trousseau Hospital, GH HUEP, Paris, France.
  • Preudhomme C; Functional Genomics Platform, Univ. Lille, Lille, France.
  • Cheok M; Department of Molecular Genetics, University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Leukemia ; 33(2): 348-357, 2019 02.
Article em En | MEDLINE | ID: mdl-30089916

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article